Elected to the Board of Directors in 2017 and Chair of the Board since 2020. Stig is regarded as an independent board member.

Special competencies

Stig has more than 35 years of strategic, commercial and leadership expertise from the life science industry, holding senior positions at H. Lundbeck and Ciba-Geigy.

Current positions

Chairman of the Board of Directors and member of the Board in several private and publicly listed  biotechnology companies, including Dizlin AB, StemMedical and SSI Diagnostica. In addition, Stig is Operating Partner in the private equity fund Catacap.


Stig holds an M.Sc. in Economics from Aalborg University, Denmark.